SUNNYVALE, Calif., Sept. 14 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc. , a biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of immune mediated diseases and cancer, today announced that it will report financial results for the fourth quarter and fiscal year ended June 30, 2009 after the NASDAQ market closes on Thursday September 17, 2009 at 1:30 p.m. PDT (4:30 p.m. EDT). To participate in the conference call, please dial 866-642-7062 for domestic callers and 706-643-1591 for international callers. The conference ID is 30472935. To access the audio broadcast or the subsequent archived recording, log on to http://ir.pharmacyclics.com/events.cfm. The archived version of the webcast will be available on the company’s website for one month.
SOURCE Pharmacyclics, Inc.
CONTACT: Ramses Erdtmann, Vice President of Finance of Pharmacyclics, +1-
408-215-3325
Web site: http://www.pharmacyclics.com/
